
On Wednesday, senators Amy Klobuchar and Mike Lee sent a letter calling on the Justice Department to keep looking into Ticketmaster over concerns that it holds monopoly power.
In the letter, addressed to Jonathan Kanter, the assistant attorney general for the Antitrust Division, they said “For too long, Live Nation and Ticketmaster have wielded monopoly power anticompetitively, harming fans and artists alike.”
“As an initial matter, other than Live Nation’s executive, every witness at our hearing testified that Live Nation is harming America’s music industry,” the senators wrote. “We asked Live Nation a number of questions about competition both at the hearing and afterwards, but it has largely failed to answer them.” They added: “Live Nation’s responses amount to ‘trust us.’ We believe that is wholly insufficient.”
Related: DOJ Opens Antitrust Probe Into Ticketmaster
The Senate Judiciary subcommittee held a hearing last month to examine the outsize role of Ticketmaster, which merged with Live Nation in 2010. The issues arose ticketing issues that left thousands of Taylor Swift fans in their hunt for tickets to a coming tour.
In the fall of 2022, Klobuchar wrote to Ticketmaster questioning the company after it said it would cancel public sale of tickets for Swift’s coming tour after lengthy wait times and technical issues caused disruptions during its presale. The same month, The New York Times reported that the Justice Department had opened an antitrust investigation into Live Nation.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas